An oncogenic role for sphingosine kinase 2

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Sphingosine kinases (SK1 and SK2) produce sphingosine 1-phosphate, a key signaling lipid.
• SK1's role in cancer is established, but SK2's function remains unclear, with conflicting reports on its pro- or anti-cancer effects.

Purpose of the Study:

• To investigate the distinct roles of sphingosine kinase 2 (SK2) in cancer development.
• To clarify the impact of varying SK2 expression levels on cell proliferation, survival, and oncogenesis.

Main Methods:

• Analysis of human cancer gene expression data to determine SK2 upregulation.
• Experimental manipulation of cellular SK2 levels to assess effects on proliferation, survival, and ceramide levels.
• Evaluation of SK2 localization (nuclear vs. plasma membrane) and extracellular S1P formation.

Main Results:

• SK2 is upregulated in many human cancers, albeit to a small extent.
• High-level SK2 overexpression reduced proliferation and survival, increasing ceramide.
• Low-level SK2 overexpression enhanced cell survival and proliferation, induced neoplastic transformation, and altered SK2 localization and S1P production.

Conclusions:

• SK2 exhibits context-dependent roles in cancer, with low-level expression promoting oncogenesis.
• Findings support the development of SK2-specific inhibitors as a therapeutic strategy against cancer.